1. Celltech Therapeutics Limited (19 from 81 patents)

2. Ucb Pharma, S.a. (7 from 179 patents)

3. Celltech R&d Limited (7 from 68 patents)

4. Ucb Biopharma Sprl (6 from 138 patents)

5. Ucbbiopharma Srl (1 from 109 patents)

6. Celltech Limited (1 from 42 patents)

1. 10883996 - Methods of identifying signaling modulators of the trimeric TNFa

2. 10273247 - Imidazothiazole derivatives as modulators of TNF activity

3. 10087179 - Fused tricyclic imidazole derivatives as modulators of TNF activity

4. 9932343 - Fused tricyclic benzimidazoles derivatives as modulators of TNF activity

5. 9890174 - Fused Tricyclic imidazole derivatives as modulators of TNF activity

6. 9868749 - Fused imidazole and pyrazole derivatives as modulators of TNF activity

7. 9815797 - Fused bicyclic heteroaromatic derivatives as modulators of TNF activity

8. 8710054 - Fused thiazole derivatives as kinase inhibitors

9. 8338592 - Fused thiazole derivatives as kinase inhibitors

10. 8324204 - Fused thiophene derivatives as kinase inhibitors

11. 8242116 - Fused thiazole derivatives as kinase inhibitors

12. 8168634 - Thiazole derivatives as kinase inhibitors

13. 7888344 - Fused thiazole derivatives as kinase inhibitors

14. 7795256 - Thieno-pyridinone derivatives as kinase inhibitors

15. 6780874 - Enamine derivatives